IO Biotech Inc.

NASDAQ: IOBT · Real-Time Price · USD
2.15
0.87 (67.97%)
At close: Aug 15, 2025, 3:59 PM
1.99
-7.40%
After-hours: Aug 15, 2025, 07:58 PM EDT

IO Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-95.49M -86.08M -71.46M -67.88M
Depreciation & Amortization
849K 756K 540K 2K
Stock-Based Compensation
6.53M 8.06M 7.04M 1.79M
Other Working Capital
1.4M 5.99M 4.12M -4.18M
Other Non-Cash Items
3.59M -331K -130K 26.22M
Deferred Income Tax
n/a n/a 87K -2K
Change in Working Capital
2.18M 5.86M 4.19M -776K
Operating Cash Flow
-82.35M -71.74M -59.73M -40.65M
Capital Expenditures
-44K -323K -690K -153K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-44K -323K -690K -153K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -3.2M n/a -12.11M
Financial Cash Flow
n/a 71.86M n/a 252.95M
Net Cash Flow
-83.16M 603K -68.94M 208.39M
Free Cash Flow
-82.39M -72.06M -60.42M -40.8M